Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191


Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.

Mulik S, Xu J, Reddy PB, Rajasagi NK, Gimenez F, Sharma S, Lu PY, Rouse BT.

Am J Pathol. 2012 Aug;181(2):525-34. doi: 10.1016/j.ajpath.2012.04.014. Epub 2012 May 31.


Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.

Rajasagi NK, Bhela S, Varanasi SK, Rouse BT.

J Leukoc Biol. 2017 Nov;102(5):1159-1171. doi: 10.1189/jlb.3HI1216-511RR. Epub 2017 Jun 5.


IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection.

Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK, Rouse BT.

J Immunol. 2012 Apr 1;188(7):3434-46. doi: 10.4049/jimmunol.1102602. Epub 2012 Feb 29.


Role of miR-155 in the pathogenesis of herpetic stromal keratitis.

Bhela S, Mulik S, Gimenez F, Reddy PB, Richardson RL, Varanasi SK, Jaggi U, Xu J, Lu PY, Rouse BT.

Am J Pathol. 2015 Apr;185(4):1073-84. doi: 10.1016/j.ajpath.2014.12.021. Epub 2015 Feb 18.


Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis.

Gimenez F, Mulik S, Veiga-Parga T, Bhela S, Rouse BT.

PLoS One. 2015 Dec 31;10(12):e0141925. doi: 10.1371/journal.pone.0141925. eCollection 2015.


An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.

Sharma S, Mulik S, Kumar N, Suryawanshi A, Rouse BT.

J Virol. 2011 Jun;85(12):5995-6007. doi: 10.1128/JVI.00034-11. Epub 2011 Apr 6.


Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.

Bhattacharjee PS, Neumann DM, Foster TP, Bouhanik S, Clement C, Vinay D, Thompson HW, Hill JM.

Exp Eye Res. 2008 Aug;87(2):122-30. doi: 10.1016/j.exer.2008.05.007. Epub 2008 May 18.


Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor.

Suryawanshi A, Mulik S, Sharma S, Reddy PB, Sehrawat S, Rouse BT.

J Immunol. 2011 Mar 15;186(6):3653-65. doi: 10.4049/jimmunol.1003239. Epub 2011 Feb 16.


Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions.

Rajasagi NK, Suryawanshi A, Sehrawat S, Reddy PB, Mulik S, Hirashima M, Rouse BT.

J Immunol. 2012 May 1;188(9):4631-43. doi: 10.4049/jimmunol.1103063. Epub 2012 Mar 30.


CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.

Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT.

J Immunol. 2004 Jan 15;172(2):1237-45.


The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.

Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ.

PLoS Pathog. 2011 Oct;7(10):e1002278. doi: 10.1371/journal.ppat.1002278. Epub 2011 Oct 6.


Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.

Yao HW, Chen SH, Li C, Tung YY, Chen SH.

J Virol. 2012 Aug;86(16):8559-67. doi: 10.1128/JVI.00505-12. Epub 2012 May 30.


Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK).

Hosseini H, Khalili MR.

Med Hypotheses. 2007;69(3):568-70. Epub 2007 Mar 21.


Herpes simplex keratitis.

Kaye S, Choudhary A.

Prog Retin Eye Res. 2006 Jul;25(4):355-80. Epub 2006 Jun 27. Review.


Expression, Inducers and Cellular Sources of the Chemokine MIG (CXCL 9), During Primary Herpes Simplex Virus Type-1 Infection of the Cornea.

Molesworth-Kenyon SJ, Milam A, Rockette A, Troupe A, Oakes JE, Lausch RN.

Curr Eye Res. 2015;40(8):800-8. doi: 10.3109/02713683.2014.957779. Epub 2014 Sep 10.


Supplemental Content

Support Center